Clinical Trial Results: A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL [Phase 2]

View source ↗

Summary

A phase 2 pilot study evaluating metformin therapy in patients with relapsed and untreated chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Relapsed Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2026-07-20